PortfoliosLab logo
PCVX vs. DLR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PCVX and DLR is 0.50, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.5

Performance

PCVX vs. DLR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vaxcyte, Inc. (PCVX) and Digital Realty Trust, Inc. (DLR). The values are adjusted to include any dividend payments, if applicable.

0.00%50.00%100.00%150.00%200.00%250.00%300.00%350.00%NovemberDecember2025FebruaryMarchApril
25.81%
39.40%
PCVX
DLR

Key characteristics

Sharpe Ratio

PCVX:

-0.60

DLR:

0.60

Sortino Ratio

PCVX:

-0.49

DLR:

1.00

Omega Ratio

PCVX:

0.91

DLR:

1.13

Calmar Ratio

PCVX:

-0.60

DLR:

0.60

Martin Ratio

PCVX:

-1.64

DLR:

1.55

Ulcer Index

PCVX:

27.66%

DLR:

11.32%

Daily Std Dev

PCVX:

75.85%

DLR:

29.59%

Max Drawdown

PCVX:

-76.22%

DLR:

-56.80%

Current Drawdown

PCVX:

-72.10%

DLR:

-16.83%

Fundamentals

Market Cap

PCVX:

$4.44B

DLR:

$53.84B

EPS

PCVX:

-$3.80

DLR:

$1.06

PS Ratio

PCVX:

0.00

DLR:

9.75

PB Ratio

PCVX:

1.28

DLR:

2.62

Total Revenue (TTM)

PCVX:

$0.00

DLR:

$4.45B

Gross Profit (TTM)

PCVX:

-$7.98M

DLR:

$2.10B

EBITDA (TTM)

PCVX:

-$345.48M

DLR:

$2.05B

Returns By Period

In the year-to-date period, PCVX achieves a -59.81% return, which is significantly lower than DLR's -8.81% return.


PCVX

YTD

-59.81%

1M

-52.63%

6M

-70.83%

1Y

-45.82%

5Y*

N/A

10Y*

N/A

DLR

YTD

-8.81%

1M

12.84%

6M

-11.21%

1Y

15.77%

5Y*

5.19%

10Y*

13.85%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PCVX vs. DLR — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PCVX
The Risk-Adjusted Performance Rank of PCVX is 1616
Overall Rank
The Sharpe Ratio Rank of PCVX is 1818
Sharpe Ratio Rank
The Sortino Ratio Rank of PCVX is 2424
Sortino Ratio Rank
The Omega Ratio Rank of PCVX is 2020
Omega Ratio Rank
The Calmar Ratio Rank of PCVX is 1414
Calmar Ratio Rank
The Martin Ratio Rank of PCVX is 55
Martin Ratio Rank

DLR
The Risk-Adjusted Performance Rank of DLR is 7171
Overall Rank
The Sharpe Ratio Rank of DLR is 7575
Sharpe Ratio Rank
The Sortino Ratio Rank of DLR is 6767
Sortino Ratio Rank
The Omega Ratio Rank of DLR is 6666
Omega Ratio Rank
The Calmar Ratio Rank of DLR is 7777
Calmar Ratio Rank
The Martin Ratio Rank of DLR is 7070
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PCVX vs. DLR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Vaxcyte, Inc. (PCVX) and Digital Realty Trust, Inc. (DLR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for PCVX, currently valued at -0.60, compared to the broader market-2.00-1.000.001.002.003.00
PCVX: -0.60
DLR: 0.60
The chart of Sortino ratio for PCVX, currently valued at -0.49, compared to the broader market-6.00-4.00-2.000.002.004.00
PCVX: -0.49
DLR: 1.00
The chart of Omega ratio for PCVX, currently valued at 0.91, compared to the broader market0.501.001.502.00
PCVX: 0.91
DLR: 1.13
The chart of Calmar ratio for PCVX, currently valued at -0.60, compared to the broader market0.001.002.003.004.005.00
PCVX: -0.60
DLR: 0.60
The chart of Martin ratio for PCVX, currently valued at -1.64, compared to the broader market-5.000.005.0010.0015.0020.00
PCVX: -1.64
DLR: 1.55

The current PCVX Sharpe Ratio is -0.60, which is lower than the DLR Sharpe Ratio of 0.60. The chart below compares the historical Sharpe Ratios of PCVX and DLR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2025FebruaryMarchApril
-0.60
0.60
PCVX
DLR

Dividends

PCVX vs. DLR - Dividend Comparison

PCVX has not paid dividends to shareholders, while DLR's dividend yield for the trailing twelve months is around 3.04%.


TTM20242023202220212020201920182017201620152014
PCVX
Vaxcyte, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
DLR
Digital Realty Trust, Inc.
3.04%2.75%3.63%4.87%2.62%3.21%3.61%3.79%3.27%3.58%5.62%5.01%

Drawdowns

PCVX vs. DLR - Drawdown Comparison

The maximum PCVX drawdown since its inception was -76.22%, which is greater than DLR's maximum drawdown of -56.80%. Use the drawdown chart below to compare losses from any high point for PCVX and DLR. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-72.10%
-16.83%
PCVX
DLR

Volatility

PCVX vs. DLR - Volatility Comparison

Vaxcyte, Inc. (PCVX) has a higher volatility of 66.78% compared to Digital Realty Trust, Inc. (DLR) at 11.94%. This indicates that PCVX's price experiences larger fluctuations and is considered to be riskier than DLR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%60.00%70.00%NovemberDecember2025FebruaryMarchApril
66.78%
11.94%
PCVX
DLR

Financials

PCVX vs. DLR - Financials Comparison

This section allows you to compare key financial metrics between Vaxcyte, Inc. and Digital Realty Trust, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items